| |
ESBL
|
carbapenems
|
fluoroquinolons
|
aminoglycosides
|
ceftazidime
|
piperacillin
|
cotrimoxazole
|
|---|
|
K. pneumonia
|
A
|
A
|
B
|
B
| | | |
|
other Enterobacteriaceaea
| | |
B
|
B
| | |
B
|
|
P. aeruginosa
| |
C
|
C
|
C
|
C
|
C
| |
|
A. baumannii
| |
A
|
B
|
B
|
B
| | |
-
MDR multi-drug resistant
-
a Proteus, Morganella, Serratia, Citrobacter, Enterobacter spp.
- A: presence of ESBL production or resistance against this antibacterial agent or group is sufficient to define the microorganism as being MDR
- B: resistance against 2 antibacterial agents or against at least 2 of the indicated groups is required to define the microorganism as being MDR
- C: resistance against 3 antibacterial agents or against antimicrobial agents from at least 3 of the indicated groups is required to define the microorganism as being MDR
